Galvão-Coelho N

Postgraduate Program in Mental Health and Behavioral Sciences, Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Advanced Research Center with Psychedelics, Federal University of Rio Grande do Norte, Natal, RN, Brazil; Laboratory of Hormone Measurement, Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, RN, Brazil; Onofre Lopes University Hospital, Federal University of Rio Grande do Norte, Natal, RN, Brazil; Postgraduate Program in Psychobiology, Federal University of Rio Grande do Norte, RN, Brazil; Department of Physiology and Behavior, Federal University of Rio Grande do Norte, RN, Brazil. Electronic address: nicole.galvao@ufrn.br.

10 papers · 2 preprints · ORCID

ArticleKetamine

Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy.

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Europe PMC2026
ArticleDMT

Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression.

Bolcont R, Palhano-Fontes F, Barros H +6

Europe PMC2026
PreprintKetamine

Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Europe PMC2026
ArticleDMT

Corrigendum to Safety, tolerability and subjective effects of vaporized N, N-Dimethyltryptamine: A randomized double-blind clinical trial [European Neuropsychopharmacology 97 (2025) 16-27].

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2026
ArticlePsilocybin

Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.

Varela YM, de O Tavares VD, Delgado LM +12

Europe PMC2026
ArticleDMT

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.

Perkins D, Halman A, Urokohara A +7

Europe PMC2025
ArticleDMT

Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial.

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2025
ArticlePsilocybin

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.

Falchi-Carvalho M, Palhano-Fontes F, Wießner I +21

Europe PMC2025
ArticleAyahuasca

The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression.

Falchi-Carvalho M, Barros H, Bolcont R +16

Europe PMC2025
ArticleAyahuasca

Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset.

Perkins D, Sarris J, Cowley-Court T +7

Europe PMC2026
PreprintAyahuasca

The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression

Falchi-Carvalho M, Barros H, Bolcont R +15

Europe PMC2024
ArticlePsilocybin

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.

Falchi-Carvalho M, Wießner I, Silva SRB +15

Europe PMC2024